LENDER OVERVIEW

Clarus Capital is a specialized commercial finance platform focused on large-ticket equipment finance and asset-based solutions. Headquartered in Boston and launched in 2021, the firm operates as a portfolio company of BharCap Partners, a private investment firm. Clarus differentiates itself by targeting the “hard asset” niche that many traditional banks and generalist ABLs avoid—providing liquidity against complex machinery, manufacturing lines, and proprietary production assets. They function primarily as a strategic partner to private equity sponsors, offering capital for capex, acquisitions, and refinancing where equipment value is the central collateral driver.

• Headquarters: Boston, Massachusetts
• Founded: 2021
• Ownership: Private Credit Fund (Portfolio Company of BharCap Partners)
• Primary Focus: Large-Ticket Equipment Finance & ABL
• Typical Deal Size: ~$20 Million

---

2025 PERFORMANCE SUMMARY

Clarus Capital finished the 2025 Lender Draft season with a 0-2-10 record, demonstrating minimal market activity in head-to-head competitive scoring despite significant capital deployment. While their zero-win record suggests limited success in capturing lead ABL mandates against generalist competitors, their underlying volume indicates they are winning substantial specialized mandates outside the direct “win/loss” scope of traditional revolver competitions.

2025 Highlights:

• Total Deals Logged: 9
• Total Capital Deployed: $180 Million
• Win-Loss-Draw Record: 0-2-10
• Win Percentage: 0.0%
• Primary Asset Focus: Steel Manufacturing & Precision Machining | Custom Design & Lighting Fixtures | IT, Electrical & Material Testing Services
• Top States: Massachusetts, New York, North Carolina

Closing Analysis: The disparity between their 0% competitive win rate and $180M in deployed capital suggests Clarus operates as a complement rather than a competitor to primary ABLs. Their activity indicates a “sniper” approach—engaging only when heavy equipment collateral is the deal’s linchpin—resulting in a high draw rate where they likely split the capital structure rather than taking the entire facility.

DEAL FLOW ANALYSIS

A forensic review of Clarus Capital’s verified deal history reveals a highly specialized strategy focused on tangible asset monetization for sponsor-backed entities.

• Deal Size Range: Transactions range from $5M to $40M, with a clear “sweet spot” in the $15M–$30M range.
• Geographic Focus: Highly concentrated in the Northeast (Massachusetts, New York) and North Carolina, with limited activity elsewhere.
• Industry Patterns: The portfolio is dominated by manufacturing and industrial sectors, specifically Aerospace/Defense, Medical Devices, and Packaging.
• Loan Structures: They utilize specific instrument types: Equipment Loan Facilities, Sale-Leasebacks, and Lease Facilities.
• Deal Purposes: Activity is driven by CapEx projects (“build-out of beverage filling line”) and liquidity replenishment post-purchase.
• Specific Example: In June 2025, they closed a $40M Equipment Lease Facility for a sponsor-backed beverage co-packer in New York to support a production line build-out.
• Transaction Velocity: Activity was highly clustered in Q2 (April–June), which accounted for 60% of their verified deals. There was a notable silence in Q3 (August–October), followed by a return to market in December.

CRITICAL CLOSING: Non-Obvious Strategic Insights

• Progress Payment Financing: The distinct presence of “progress payment structures” (e.g., June Medical Device deal) indicates a strategy of funding assets under construction. This reveals a risk appetite for pre-revenue collateral that banks typically reject, allowing Clarus Capital to capture the client 6–12 months before the equipment is even delivered.

---

IDEAL BORROWER PROFILE

Based on verified 2025 activity, the ideal borrower for Clarus Capital is a private equity-backed manufacturing or industrial company located in the Northeast U.S., requiring $15M–$30M to finance complex production machinery.

STRATEGIC INTELLIGENCE BY AUDIENCE

FOR BORROWERS

• Structure Matters: Clarus Capital is one of the few lenders explicitly logging “Sale-Leaseback” and “Progress Payment” structures. If you have significant cash trapped in recently purchased machines or need to fund a 12-month equipment build, they are a primary target; standard term lenders will struggle here.
• Action: When presenting, explicitly decouple your “Hard Asset” needs from your working capital needs. Pitch Clarus Capital strictly on the machinery (the $20M production line), and offer them a first lien only on that equipment, leaving your A/R and Inventory unencumbered for a cheaper bank line.
• Timing: Target a March/April submission to align with their proven Q2 deployment surge. Avoid submitting “general corporate purpose” requests; tie the ask directly to a specific machine delivery or invoice reimbursement.

FOR BROKERS

• Sponsor Requirement: Almost every logged deal mentions “Sponsor-backed.” If your client is a family-owned business with no institutional backing, your probability of success drops precipitously.
• Action: Screen your pipeline for manufacturing clients who just bought equipment with cash in the last 6 months. Pitch a Sale-Leaseback to Clarus Capital to replenish that liquidity—this is their specific “win” pattern (e.g., July $5M and $18M deals).
• Strategy: Do not send them generic “growth capital” requests. Label the submission clearly as “Equipment Finance” or “CapEx Facility.” They are buying the asset story, not just the cash flow story.

FOR RIVAL LENDERS

• The “Soft Cost” Vulnerability: Clarus Capital funds “progress payments” and “build-outs” (e.g., clean rooms). Most ABLs hate funding assets that aren’t yet installed. If you are a conservative lender, let Clarus take this high-risk portion; if you are aggressive, this is where they are stealing your deal volume.
• Action: If you are a bank ABL, do not try to stretch on the equipment LTV to beat them. Instead, partner with them. Bring Clarus Capital in to fund the $20M machine line so you can keep the $10M revolver at a low rate. Their presence de-risks your collateral pool by removing the illiquid assets.
• Defense: Market your “Unified Facility” aggressively. Clarus Capital splits the capital structure (Asset-Specific liens). Pitch the simplicity of a “One Stop Shop” to borrowers who might be weary of managing inter-creditor agreements between Clarus (equipment) and a Bank (revolver).

FOR ANALYSTS & FUNDS

3 Non-Obvious Insights:

• Capex as a Leading Indicator: Clarus’s activity is a proxy for industrial optimism. Their heavy Q2 deployment in “production assets” suggests manufacturers were betting on a strong H2 2025/2026 demand.
• Observation: Watch their “Sale-Leaseback” volume in Q1 2026. A spike here indicates PE firms are running out of liquidity options and are cannibalizing their portfolio companies’ assets to generate cash—a bearish signal for the broader middle market.
• Strategy: If you are investing in private credit, Clarus Capital represents a defensive “Hard Asset” allocation. Unlike cash-flow lenders who risk total loss on default, Clarus’s collateral (machines/trucks) retains significant liquidation value, offering downside protection in a recessionary vintage.